Generic Drugs (Dapagliflozin and Saxagliptin) Treat Type 2 Diabetes Patients With Controlled Cancers
Clinical trial NCT07033585 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07033585
- Sponsor
- Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-15
- Primary completion
- 2026-10-18
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.